Clinical trials
Phase 1 Thyroid Neoplasms trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 4 |
| Completed | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Pfizer | 2 |
| AHS Cancer Control Alberta | 1 |
| Erasca, Inc. | 1 |
| MacroGenics | 1 |
| Theratechnologies | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Neoplasms | 8 |
| Melanoma | 7 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Glioma | 3 |
| Pancreatic Neoplasms | 3 |
| Prostatic Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.